2021年6月22日全球新冠肺炎疫情及疫苗接种简报:日新增28.8万,国内疫苗接种超10亿剂次,Delta毒株导致全球多地疫情反弹

2021-06-22 MedSci整理 MedSci整理

截至北京时间2021年6月22日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17953万例,新增272,240例,达到179,530,09

截至北京时间2021年6月22日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过17953万例,新增272,240例,达到179,530,097例。累计死亡病例388.8万例,达到3,888,055例。新增死亡为5,640例。康复为164,155,069例,重症和危重症病人达到82,659例;全球新冠确诊病例超过100万例的国家达28个,96个国家病例超10万例。昨日报道:2021年6月21日全球新冠肺炎疫情及疫苗接种简报:日新增28.8万,国内疫苗接种超10亿剂次,Delta毒株导致全球多地疫情反弹

 

美国公布5500万剂新冠疫苗全球分配计划

美国白宫21日公布了5500万剂新冠疫苗全球分配计划。美国总统拜登5月曾表示,美国将在6月底前向全球分享8000万剂新冠疫苗。6月3日,拜登公布了首批2500万剂新冠疫苗的全球分配计划。

新冠幸存者或出现大脑灰质流失,主要关联嗅觉和味觉区域

根据英国生物库(UK Biobank)收集的数据,一项新研究表明,新冠幸存者可能会随着时间的推移出现大脑灰质流失。这项涉及782名志愿者的长期实验,比较了流感大流行前人们的大脑扫描图。为了对大流行前和大流行后的大脑扫描进行类比,研究人员随后邀请了394名COVID-19幸存者和388名健康志愿者返回进行后续扫描。

德国总理默克尔:新冠肺炎疫情带来时代变革

当天时间21日,德国总理默克尔在联盟党(由基民盟和基社盟组成的执政党)的党内会议上表示,“随着新冠肺炎疫情大流行的发展,世界将再经历一次重新洗牌。”她认为,不仅德国,整个世界都正处于一个需要进行深刻改革的时代。默克尔指出,“williamhill asia 还有更多工作需要迎头赶上”,而数字化和创新无疑将成为重中之重。

英国将全面解封日推迟至7月19日

英国政府原计划在6月21日夏至日到来之际,全面解封,但是随着印度最早发现的Delta变异新冠病毒在英国加剧传播,英国政府决定将全面解封日推迟至7月19日。当地时间6月21日下午,大批反封锁抗议者在英国议会大厦及首相府周边聚集,一些抗议者还试图阻断交通,遭到警察驱逐。据伦敦大都会警察局在社交媒体发布的消息,一些抗议者向首相府唐宁街内投掷网球,上面写着抗议标语,警方已经逮捕至少8名抗议者。当日,苏格兰政府在上周五(18日)发出的禁止英格兰曼彻斯特旅客前往苏格兰的旅行禁令也正式生效 。

土耳其7月1日起全面解除“禁足令”

当地时间6月21日,土耳其总统埃尔多安发表全国电视讲话称,将于7月1日起全面解除“禁足令”。此外,跨省旅行禁令和乘坐城市公共交通工具的限制措施也将取消,公营机构将会恢复正常工作时间。埃尔多安表示,内政部将公布具体政策。

全球疫苗接种概况

Country
Cumulative COVID-19 vaccinations doses
World 2.66 billion
Asia 1.58 billion
Upper middle income 1.37 billion
China 1.03 billion
High income 903.83 million
Europe 455.42 million
North America 411.19 million
Lower middle income 375.48 million
European Union 323.97 million
United States 317.97 million
India 274.29 million
South America 159.23 million
Brazil 86.96 million
United Kingdom 74.58 million
Germany 66.45 million
England 62.64 million
France Jun 19, 2021 48.21 million
Italy 46.02 million
Africa 45.33 million
Turkey 42.61 million
Mexico Jun 19, 2021 40.03 million
Spain Jun 17, 2021 35.41 million
Indonesia 35.28 million
Russia 34.90 million
Canada 32.19 million
Japan 31.59 million
Poland 26.49 million
Chile Jun 18, 2021 21.39 million
Argentina 18.09 million
South Korea 17.95 million
Morocco Jun 19, 2021 17.49 million
Saudi Arabia 16.65 million
Colombia 14.95 million
United Arab Emirates 14.51 million
Netherlands 12.93 million
Pakistan Jun 19, 2021 12.75 million
Israel 10.65 million
Bangladesh Jun 19, 2021 10.08 million

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-07-16 ms9000000012500818

    持续关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 ms1000000001278051

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 ms7000000277652389

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 肖肖肖肖

    学习

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1000006, encodeId=bfb81000006e0, content=持续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=343e5530907, createdName=ms9000000012500818, createdTime=Fri Jul 16 12:58:50 CST 2021, time=2021-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258035, encodeId=1c3e125803520, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526003, encodeId=4b971526003a9, content=<a href='/topic/show?id=81c93e74709' target=_blank style='color:#2F92EE;'>#反弹#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37747, encryptionId=81c93e74709, topicName=反弹)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=17d711676114, createdName=meichuangyi, createdTime=Wed Jun 23 22:53:12 CST 2021, time=2021-06-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975915, encodeId=f7d19e59156a, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/5920737516594ef3bbd30b8bf54b1aac/6100bbfa8ea94386839516360b9b80c8.jpg, createdBy=c1dc5531587, createdName=ms1000000001278051, createdTime=Tue Jun 22 20:13:21 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975784, encodeId=fa699e5784c9, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bb1f5531082, createdName=ms7000000277652389, createdTime=Tue Jun 22 12:24:15 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975766, encodeId=5c009e5766cc, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210622/0ff31a8b553f430faa1402b6fcf742ef/c74d11523587446c84b144b663ec49b0.jpg, createdBy=0dcf5173856, createdName=肖肖肖肖, createdTime=Tue Jun 22 11:15:25 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029633, encodeId=b3ed10296335d, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Tue Jun 22 10:53:12 CST 2021, time=2021-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=975719, encodeId=adcc9e571998, content=583, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6b95530918, createdName=ms1000000401552930, createdTime=Tue Jun 22 09:31:08 CST 2021, time=2021-06-22, status=1, ipAttribution=)]
    2021-06-22 ms1000000401552930

    583

    0

相关威廉亚洲官网

广东新增6例新冠肺炎感染者,广东省加快疫苗接种,建立免疫屏障阻遏病毒传播

6月18日0-24时,全省新增6例本土确诊病例,广州报告2例,深圳报告2例,佛山报告1例,东莞报告1例。截至6月18日24时,全省累计报告新冠肺炎确诊病例2680例(境外输入1117例)。目前在院22

浙江温州发现1例境外输入病例,曾在京隔离

据温州发布微博(@温州发布)通报,浙江温州发现1例境外输入病例,曾在京隔离。

国家卫健委: 昨日新增确诊病例24例,其中本土11例均在广东

6月4日0—24时,31个省(自治区、直辖市)和新疆生产建设兵团报告新增确诊病例24例,其中境外输入病例13例(广东5例,福建3例,北京2例,上海1例,四川1例,云南1例),本土病例11例

我国台湾新增107例本土确诊新冠肺炎、11例死亡,本土病例日增数已连续37天超百例

6月20日,我国台湾“中央流行疫情指挥中心”通报数据称,当天我国台湾新增109例新冠肺炎确诊病例,其中107例本土以及2例境外输入。同时,新增11例死亡病例。

美国国立卫生研究院研究发现2019年12月新冠病毒已在美国传播

NIH研究提供了美国早期SARS-CoV-2感染的新证据。

巴西新冠病毒死亡人数超过50万

巴西新冠病毒造成的死亡人数已经超过了50万。